Tokyo, Mar 21, 2006 (JCN) - ASKA Pharmaceutical and Takeda Pharmaceutical have signed a licensing agreement with BioNumerik Pharmaceuticals and KI Pharmaceuticals, a joint venture company of ASKA and BioNumerik, for Tavocept, a chemoprotective agent developed by BioNumerik.
